atopic dermatitis
Conditions
Interventions
Intervention group:Receive 12 weeks of standardized MTM services led by clinical pharmacists
control:no
Sponsors
shanghai skin disease hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Age =18 years old, =70 years old, male and female; ? Patients with atopic dermatitis diagnosed in tertiary grade A hospitals; ? SCORAD score was =25; (4) Active maintenance therapy of TCS/TCI, NB-UVB, UVA1, immunosuppressants, glucocorticoids, and immunobiological agents (one of the therapeutic methods) were used in treatment; (5) Able to communicate well with researchers and comply with protocol requirements for follow-up; ? Predicted survival =12 months; ? Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: ? 28 days before enrollment, subjects participated in other clinical trials; ? Patients with malignant tumors or blood diseases during radiotherapy and chemotherapy, targeted therapy, immunotherapy, and cell therapy; ? Patients scheduled to undergo major surgery during the study period; ? Subjects with unstable mental illness, alcoholism, drug or substance abuse;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grading method of atopic dermatitis score severity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Eczema area and severity index;Incidence of adverse events during the study period;Treatment compliance during the study (actual dosage/dosage to be used);All-cause hospitalization rate during the study period; | — |
Countries
China
Contacts
Public Contactzhuquangang
shanghai skin disease hospital
Outcome results
None listed